-
公开(公告)号:US20190194264A1
公开(公告)日:2019-06-27
申请号:US16319835
申请日:2017-08-11
申请人: UNIVERSITÉ DE NAMUR
IPC分类号: C07K14/195 , C12P21/02
CPC分类号: C07K14/195 , C07K2319/035 , C12P21/02 , C12Y302/01018 , C12Y402/02001
摘要: Described herein are polypeptides comprising a lipoprotein export signal, polypeptide precursors comprising a lipoprotein export signal, nucleic acids encoding said polypeptides or polypeptide precursors, recombinant expression vectors comprising nucleic acids encoding said lipoprotein export signal and/or polypeptides or polypeptide precursors, and 5 recombinant host cells comprising these vectors. The application further provides uses of these polypeptides, polypeptide precursors, nucleic acids, recombinant expression vectors and recombinant host cells.
-
公开(公告)号:US20210260572A1
公开(公告)日:2021-08-26
申请号:US17256646
申请日:2019-07-03
申请人: UNIVERSITÉ DE NAMUR , STÛV
发明人: Tarek Barakat , Bao-Lian Su
IPC分类号: B01J37/03 , B01J21/12 , B01J21/06 , B01J21/14 , B01J35/10 , B01J37/04 , B01J37/08 , B01J35/02 , B01D53/86
摘要: The invention relates to a process of manufacture of a solid catalyst made of a support coated with a thin catalytic layer and to a process for eliminating gaseous and/or particulate pollutants in an exhaust gaz. The process of the invention of manufacture of a solid catalyst (1) comprising a support (2) coated with a catalytic layer (3) comprises the following steps: a) preparing a solution A by dissolving alkoxide and/or chloride precursors of at least one metal selected in the group consisting of Al, Si, Ti, Zr, Fe, Zn, Nb, V and Ce in a solvent S1 having a partition coefficient lower than 1 and containing less than 5% by volume of water, b) preparing a solution B containing a surfactant, an organic acid and/or hydrochloride acid (HCl) in a solvent S2 having a partition coefficient lower than 5, preferably less than 2, even more preferably less than 1, c) mixing solution A and solution B together, thereby obtaining a washcoat solution C, d) dip-coating the support (2) having OH groups at its surface into washcoat solution C, e) drying the coated support (2) obtained in step d), f) calcinating the dried coated support (2) obtained in step e). The process of the invention finds application in the field of elimination of VOC's, CO and/or particulate pollutants in an exhaust gaz.
-
公开(公告)号:US20150109655A1
公开(公告)日:2015-04-23
申请号:US14398067
申请日:2013-04-25
申请人: Université de Namur
发明人: Jean-Pol Vigneron , Olivier Deparis , Priscilla Simonis , Eric Gaigneaux , Mohammed N. Ghazzal , Joël De Coninck , Hakim Kebaïli
CPC分类号: G02B26/004 , G02B1/005 , G02B5/285 , G02B26/08 , G02B2207/107
摘要: Functional multilayer systems and are used in the manufacture of various devices such as detecting and sensor devices. More specifically, porous multilayer systems are capable of switching from a transparent state to a Bragg reflector state by introducing a suitable composition into the porous multilayer system, or via displacement of a suitable composition through the porous multilayer system.
摘要翻译: 功能多层系统,用于各种设备的制造,如检测和传感器设备。 更具体地,多孔多层系统能够通过将合适的组合物引入到多孔多层体系中,或者通过通过多孔多层体系置换合适的组合物,从透明状态切换到布拉格反射器状态。
-
公开(公告)号:US20210048443A1
公开(公告)日:2021-02-18
申请号:US16967468
申请日:2019-02-06
摘要: The application provides a method for the in vitro diagnosis of a haemostasis disorder in a plasma sample obtained from a subject comprising the steps of a) contacting a plasma sample obtained from said subject with activated charcoal; b) recovering said plasma sample from said activated charcoal; and c) determining the coagulation ability of said plasma sample obtained under step (b) wherein the ability of said plasma sample to coagulate is indicative of the presence, progression, or severity of a haemostasis disorder in said subject, and optionally of the nature of the haemostasis disorder.
-
公开(公告)号:US20200002750A1
公开(公告)日:2020-01-02
申请号:US16482769
申请日:2018-02-16
摘要: Described herein are methods for identifying C. canimorsus in a sample as one of serotype A, serotype B, serotype C, serotype D or serotype E, amplification primer pairs, sets of primer pairs, oligonucleotide probes, sets of oligonucleotide probes, polyclonal antibodies, sets of polyclonal antibodies and kits that can be used for such methods. The application further provides polyvalent vaccines for the protection against an infection with C. canimorsus, methods of preparing said polyvalent vaccines and uses of these polyvalent vaccines.
-
-
-
-